We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

18 hedge funds and large institutions have $6.22M invested in Bio-Path Holdings Inc in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,889% more capital invested

Capital invested by funds: $208K → $6.22M (+$6.01M)

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

6% more funds holding

Funds holding: 17 → 18 (+1)

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
4
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.28M
2
BlackRock
BlackRock
New York
+$363K
3
Two Sigma Investments
Two Sigma Investments
New York
+$227K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$180K
5
VF
Virtu Financial
New York
+$151K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$9K
2
RCA
Rowland Carmichael Advisors
Arizona
-$8K
3
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$7K
4
Northern Trust
Northern Trust
Illinois
-$3K
5
TSS
Two Sigma Securities
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$3.31M +$1.28M +6,979 +607%
BlackRock
2
BlackRock
New York
$813K +$363K +1,976 +10,400%
Vanguard Group
3
Vanguard Group
Pennsylvania
$516K +$180K +980 +343%
Two Sigma Investments
4
Two Sigma Investments
New York
$504K +$227K +1,236 New
UOTTAIMCU
5
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$391K – – –
VF
6
Virtu Financial
New York
$336K +$151K +823 New
G
7
Gainplan
Michigan
$204K +$91.9K +500 New
Barclays
8
Barclays
United Kingdom
$43K +$19.3K +105 New
UBS Group
9
UBS Group
Switzerland
$32K +$14.3K +78 New
Wells Fargo
10
Wells Fargo
California
$23K +$9.93K +54 +1,800%
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$21K – – –
AG
12
Advisor Group
Arizona
$9K +$4.05K +22 New
CAPTRUST Financial Advisors
13
CAPTRUST Financial Advisors
North Carolina
$5K – – –
Morgan Stanley
14
Morgan Stanley
New York
$2K +$919 +5 New
WAM
15
Wealthspire Advisors (Maryland)
Maryland
$2K +$919 +5 New
AF
16
Advisornet Financial
Minnesota
$1K – – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$9K -131 Closed
RCA
18
Rowland Carmichael Advisors
Arizona
– -$8K -110 Closed
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
– -$7K -105 Closed
Northern Trust
20
Northern Trust
Illinois
– -$3K -44 Closed
TSS
21
Two Sigma Securities
New York
– -$3K -40 Closed
RJFSA
22
Raymond James Financial Services Advisors
Florida
– -$2K -36 Closed
California Public Employees Retirement System
23
California Public Employees Retirement System
California
– -$2K -29 Closed

BPTH Hedge Fund Activity: Q1 2019 in Review

18 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2019, worth a combined $6.22M — up 2,889% from $208K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BPTH positions and 7 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.28M. The largest seller was Geode Capital Management, exiting entirely with an estimated $9K sold.

  • 18 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2019, up from 17 in Q4 2018.
  • Funds reported $6.22M of Bio-Path Holdings Inc stock for Q1 2019, up 2,889% quarter-over-quarter.
  • 8 funds opened new Bio-Path Holdings Inc positions in Q1 2019 and 7 closed out, a net change of +1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q1 2019 was Renaissance Technologies, an estimated $1.28M added.
  • The largest Bio-Path Holdings Inc seller in Q1 2019 was Geode Capital Management, an estimated $9K sold.

Based on aggregated 13F filings for Q1 2019.